Bayerische Motoren Werke ADR (BMWYY)

In medical imaging, technology often races ahead of regulation. A recent proposal from the Centers for Medicare & Medicaid Services (CMS) underscores this tension: the agency is opting not to mandate radiation dose tracking for CT scans by 2027. While the decision reflects operational challenges hospitals face in meeting such requirements, it also highlights a growing consensus: patients, providers, and regulators all want sharper images with lower radiation exposure.

Groundbreaking research presented at the ECTRIMS 2025 conference held in Barcelona, Spain provides new insights into the ways in which menopause impacts the health implications and clinical manifestations in women who have multiple sclerosis. This study shows that changes in hormones influence the initial symptoms experienced by women with MS and also play a role in the comorbidities suffered by the affected individuals.

When drivers think about extended car warranties, the first question that usually comes to mind is simple: How much does it cost?

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company developing therapies for neurodegenerative diseases, announced the appointment of Mark Guerin, CPA, CMA, CFM, as Chief Financial Officer to help guide the Company as its lead drug candidate, buntanetap, advances through late-stage trials. Guerin previously served as CFO of Onconova Therapeutics, now Traws Pharma (NASDAQ: TRAW), where he oversaw multiple financings and a merger that formed the new entity. His earlier roles include senior finance positions at Cardiokine, Barrier Therapeutics, and Coopers & Lybrand. Guerin said he is eager to support Annovis as it works to replicate buntanetap’s early success in registrational studies and deliver solutions for patients with Alzheimer’s and Parkinson’s disease.

A recently published study by a team at the University of Chicago suggests that a carotenoid called zeaxanthin, naturally occurring in plants like kale, spinach and orange peppers, and well known for its benefits in eye health, could also play a role in supercharging the immune system during the fight against cancer.

Soligenix (NASDAQ: SNGX) is continuing to build momentum in its mission to advance HyBryte(TM), a first-in-class treatment for early-stage cutaneous T-cell lymphoma (“CTCL”). That progress is supported by results from its pivotal FLASH trial and its ongoing FLASH 2 confirmatory study. Together, the studies highlight not only the efficacy of synthetic hypericin activated by safe fluorescent light but also the company’s broader strategy to establish HyBryte as a new standard of care in a field where therapeutic innovation has lagged ( https://www.ibn.fm/G18Hp ). With statistically significant data already achieved and confirmatory enrollment well underway, Soligenix is taking important steps toward potential regulatory approvals Worldwide.

HiLine Motors, a trusted name in luxury pre-owned vehicles across the Dallas–Fort Worth area, has officially opened the doors to its brand-new, state-of-the-art auto service and repair center . Conveniently located on its dealership lot at 4480 W Plano Parkway in Plano, Texas, the new facility is open to the public and welcomes all makes and models—luxury and non-luxury alike—including vehicles still under manufacturer warranty. This expansion adds a full suite of service options to HiLine's offerings, providing customers with one-stop access to high-quality auto sales, maintenance, and repair in one location.

Fifty 1 Labs (OTC: FITY), a Nevada-based holding company focused on AI-driven drug repurposing and functional medicine, announced it has signed a letter of engagement with a Public Company Accounting Oversight Board registered auditing firm to conduct audits of its 2024 and 2025 financial statements. The audits mark a key step in the company’s plan to uplist to the OTCQB Venture Market, which requires strict reporting and governance standards. CEO Paul Arora said the engagement underscores Fifty 1 Labs’ commitment to transparency and corporate governance, while laying the groundwork to strengthen investor confidence as it advances biotech and wellness initiatives.

A new episode of the BioMedWire Podcast shines a spotlight on Izotropic (CSE: IZO) (OTCQB: IZOZF) and its innovative approach to breast cancer imaging. Featuring IZO CEO Robert Thast, the podcast ( ibn.fm/JUWtD ) reveals how Izotropic’s proprietary Breast CT technology could transform early detection, improve patient outcomes and set the company on a trajectory toward commercial success in major healthcare markets. With both its groundbreaking science and its business vision on display, the conversation captures why Izotropic is gaining attention across the medical imaging sector.

Most American families are very concerned about health care costs, and recent policy decisions at the federal level will increase the costs that families have to incur for health care. We discuss some of those policy decisions that are causing an uptick in the cost of health care .

The new shop was built with both performance and comfort in mind. Highlights include a customer breezeway for convenient drop-offs and pickups, in-ground lifts for precision service, Italian flooring throughout the workshop, and a modern customer waiting area that reflects the company’s commitment to providing a premium experience. Every detail, from the layout of the service bays to the polished finishes, is designed around delivering white glove service that matches the level of care BMW drivers expect.

The biotechnology sector is defined by its ability to pair scientific innovation with leadership that can translate discoveries into approved therapies. This is particularly critical in oncology, where late-stage candidates must navigate complex regulatory pathways and demonstrate real clinical impact in indications with limited treatment options. Companies that combine robust intellectual property with seasoned leadership are positioned to accelerate value creation for patients and investors alike.

A grant of $2 million has been awarded to UCLA Health by a for-profit company, ViewRay Systems. The purpose of this grant is to enable the university to accelerate its research efforts in finding ways in which MRI-guided radiation therapy can be leveraged to provide targeted treatment to cancer patients.

Researchers at the University of Michigan have published a study which suggests that implementing a dietary adjustment could make glioblastoma, a deadly type of brain cancer, more susceptible to chemotherapy and radiation treatments targeting the tumors in the brain.

In a landscape where cancer and underserved diseases continue to devastate millions, the demand for groundbreaking RNA-based, immunotherapeutic, and targeted treatments has never been more urgent. Oncotelic Therapeutics (OTCQB: OTLC ) is answering this call with pioneering RNA candidates and strategic programs aimed at some of the most lethal and overlooked cancers.

Shopping for a car can feel stressful, but it doesn’t have to be. At CarHub North York Chrysler, the focus is on making the entire experience easy and straightforward. It is one of the best Chrysler, Jeep, Dodge, RAM and Fiat dealerships in Ontario. They make buying, selling, financing, and servicing your car simple, transparent, and even enjoyable.

NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company, announced the official launch of its Florida Sunshine brand of premium vitamins and supplements across U.S., UK, and European markets, with expansion to China via Alibaba’s Tmall Global expected in Q4 2025. Supported by AI-powered digital advertising and dedicated e-commerce storefronts, the rollout targets rising global demand for preventive health and wellness products. The Made-in-USA liposomal formulations include vitamins C and D3, CoQ10, and Lutein, offering advanced absorption technology for immunity, heart health, and overall wellness. CEO David Phipps said the launch positions NextPlat to capture significant growth opportunities in the multibillion-dollar nutraceuticals market.

UCLA researchers have developed a smart pen that can detect Parkinson’s during its early stages when the symptoms relied upon for the usual way to diagnose it haven’t shown up yet. Initial tests of this pen revealed an accuracy rate of 96.22%.

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company advancing imaging-based products for the detection and treatment of breast cancer, has launched a new Frequently Asked Questions page on its corporate website at www.izocorp.com/faq . The resource provides accessible information on the company’s IzoView Breast CT Imaging System, development milestones, and competitive positioning, addressing topics such as breast density, imaging workflow, and comparisons with other modalities. Optimized for search and AI platforms, the FAQ page supports Izotropic’s investor relations, clinical outreach, and advocacy initiatives.

Miami is a glamorous city that is also associated with energy and sophistication. It has been a haven of business executives, celebrities, and global travelers since its lively nightlife and its white sand beaches. To the people coming into Miami International Airport (MIA), the trip cannot just begin as you get into downtown. Rather, it […]

Northridge, CA () September 15, 2025 -- George’s Alignment & Brake Service is expanding its presence to better serve drivers in Northridge and surrounding neighborhoods.

In its most recent quarterly update, HeartBeam (NASDAQ: BEAT) is reporting that the company is on the verge of revolutionizing cardiac diagnostics with its groundbreaking ECG technology. The company is actively preparing for FDA 510(k) clearance of its innovative 12-lead ECG synthesis software for arrhythmia assessment while executing comprehensive commercial readiness plans for a technology that could transform how heart health is monitored both in clinical and home settings ( https://ibn.fm/dz7rY ).

Researchers at University of Pittsburg have found that patients who consume sucralose regularly have a lower likelihood of benefiting from immunotherapy and having longer survival times. Sucralose is an artificial sweetener that is commonly used in a variety of diet products, such as Splenda. This research is the first to connect the dietary choices that people make to groundbreaking cancer treatments.

Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company developing innovative cancer therapeutics, announced it will host a key opinion leader event on Sept. 18, 2025, at 5 p.m. ET to discuss interim efficacy results from its Phase 2 trial of lead candidate ENV105 in advanced prostate cancer. CEO Dr. John Yu said the event will highlight safety and efficacy findings from the ENV105 and apalutamide combination therapy, with expert perspectives underscoring the compound’s potential role in addressing cancer drug resistance.

On Tuesday, the U.S. federal administration published a report aimed at improving the health of children in the country. The report calls for wide-ranging policy changes and executive actions to tackle the chronic disease burden rising in the country. HHS Secretary Kennedy Jr. announced this report. However, reactions to the contents of the report have been mixed .